{
  "ticker": "JNJ",
  "target_date": "2025-05-26",
  "actual_date": "2025-05-23",
  "collected_at": "2025-12-08T11:48:32.030443",
  "price": {
    "open": 149.64,
    "high": 150.11,
    "low": 148.87,
    "close": 149.58531188964844,
    "volume": 6727300,
    "change_1d_pct": 0.22,
    "change_7d_pct": 4.5,
    "change_30d_pct": 2.86
  },
  "technicals": {
    "rsi_14": 45.52,
    "sma_20": 150.11,
    "sma_50": 152.59,
    "macd": -1.068,
    "macd_signal": -1.304,
    "macd_histogram": 0.236,
    "bb_upper": 155.55,
    "bb_lower": 144.67,
    "price_vs_sma20_pct": -0.35,
    "price_vs_sma50_pct": -1.97,
    "volume_ratio": 0.86
  },
  "fundamentals": {
    "market_cap": 489291710464,
    "pe_ratio": 19.6028,
    "forward_pe": 19.158962,
    "price_to_book": 6.163991,
    "price_to_sales": 5.3097887,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.27,
    "pct_from_52w_low": 44.36
  },
  "macro": {
    "spy": {
      "price": 575.81,
      "change_1d_pct": -0.68,
      "change_7d_pct": -1.92
    },
    "vix": {
      "level": 22.29,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.51
    },
    "dollar_index": {
      "level": 98.93
    },
    "gold": {
      "price": 3363.6
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "How To Build A $100,000 Dividend Portfolio That Could Yield 10.75% In 15 Years",
      "source": "SeekingAlpha",
      "datetime": 1748275200,
      "summary": "The Dividend Income Accelerator Portfolio targets income growth and diversification across sectors and countries. Learn why it offers strong returns and low risk.",
      "url": "https://finnhub.io/api/news?id=4bba80b64fd9b458cfb1fb516aebcdd2ca8aadeff95b4f1fe8fcb22ac8432e60"
    },
    {
      "headline": "Gilead Sciences' Best Days May Be Ahead - Here's Why",
      "source": "SeekingAlpha",
      "datetime": 1748255556,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=4dc5c6c5ff94597181eb823c3d6e672dd445702ca8558a3b0817a52051744a8c"
    },
    {
      "headline": "No Rolex For Me - I'm Buying Dividends That Pay For Life",
      "source": "SeekingAlpha",
      "datetime": 1748244600,
      "summary": "Dividend growth stocks offer reliable long-term returns. Find out how strong-yielding dividend stocks have consistently outperformed the market with lower risk.",
      "url": "https://finnhub.io/api/news?id=905cbdc8621173b6cf1ee83bd44a6bef34513918faff0cba72f542059dc35da1"
    },
    {
      "headline": "US FDA Votes in Favor of Benefit-Risk Profile of Johnson & Johnson\u2019s DARZALEX FASPRO",
      "source": "Yahoo",
      "datetime": 1748171267,
      "summary": "On May 20, Johnson & Johnson (NYSE:JNJ) announced that the FDA Oncologic Drugs Advisory Committee/ODAC voted 6-2 in favor of the benefit-risk profile of single-agent DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) for treating adult patients with high-risk smoldering multiple myeloma (HR-SMM). ",
      "url": "https://finnhub.io/api/news?id=9ec8dc60d045d12a3f13358bf5ed9005dc816c52ad9e5fa742fa5c1dd2c57070"
    },
    {
      "headline": "Generating Passive Income: 3 Top Dow Dividend Stocks to Buy for 2025 and Beyond",
      "source": "Yahoo",
      "datetime": 1748074560,
      "summary": "Chevron has hiked its dividends for 38 straight years.  Johnson & Johnson recently raised its dividend for the 63rd year in a row.  Verizon has the longest dividend growth streak in the U.S. telecom sector.",
      "url": "https://finnhub.io/api/news?id=ad244c31042eba82c891546e3b9e6769327136cbaa39781a29a7dbfd49514fac"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "13F-HR",
      "date": "2025-05-07",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000238/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746479407.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000143/xslF345X05/wk-form4_1746479407.xml"
    },
    {
      "form": "8-K",
      "date": "2025-04-30",
      "description": "jnj-20250424.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000141/jnj-20250424.htm"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877468.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000138/xslF345X05/wk-form4_1745877468.xml"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877247.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000135/xslF345X05/wk-form4_1745877247.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}